UofL receives $11.5 million to advance cancer immunotherapies

Building on more than two decades of success in cancer research, UofL is poised to advance immunotherapy with a grant of $11.5 million from the NIGMS to establish the Center for Cancer Immunology and Immunotherapy (CCII). The new center will develop and improve strategies that use the immune response to fight cancer. The five-year grant also will support young investigators and develop additional basic, translational and clinical research at the UofL Health – James Graham Brown Cancer Center.

UofL conducting clinical trial on drug for severe COVID-19 respiratory effects

The University of Louisville is conducting a clinical trial on a new treatment for critically ill COVID-19 patients meant to lessen some of the most severe and deadly respiratory effects. The treatment, a new formulation of Aviptadil (RLF-100), produced by Pennsylvania-based NeuroRx and Relief Therapeutics Holding, SA, of Geneva, works by combating cytokine storm, an unchecked overreaction of the body’s immune response. These storms can cause severe lung inflammation and stiffening that make it difficult, if not impossible, for patients to breathe on their own.

UofL Health expedites telehealth expansion in response to COVID-19 pandemic

UofL Health expanded its telehealth program to improve patient access with more than 600 of our providers, while maintaining social distancing, during the COVID-19 pandemic.

More news available at UofL Health.

Delivering health care through a new lens: smart glasses

The COVID-19 pandemic has led to the expansion of telemedicine, and as part of that expansion, faculty at the University of Louisville are piloting new smart glasses for advanced delivery of health care.

“There is both an urgent and widespread need to not only treat patients but deliver expertise and training remotely and safely to both professionals and medical learners,” said R. Brent Wright, MD, associate dean for rural health innovation at the UofL School of Medicine, who has been working with various companies to explore a smart glasses solution for telemedicine since 2014.

Long-term care facilities and emergency departments represent two of the areas with greatest need for the glasses for direct physician care during the pandemic. The UofL Trager Institute, emergency medicine and psychiatry are part of a feasibility study to test the Vuzix M400 smart glasses.